Vaccinex, Inc. (VCNX)
USD 1.0
(66.67%)
USD 1.0
(66.67%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.63 Million USD | -54.48% |
| 2022 | 7.97 Million USD | -18.96% |
| 2021 | 9.84 Million USD | -15.89% |
| 2020 | 11.7 Million USD | 154.17% |
| 2019 | 4.6 Million USD | -79.1% |
| 2018 | 22.02 Million USD | 295.12% |
| 2017 | 5.57 Million USD | 96.16% |
| 2016 | 2.84 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.36 Million USD | -67.87% |
| 2024 Q1 | 7.36 Million USD | 102.89% |
| 2023 Q2 | 3.08 Million USD | -36.98% |
| 2023 Q1 | 4.89 Million USD | -38.64% |
| 2023 FY | 3.63 Million USD | -54.48% |
| 2023 Q4 | 3.63 Million USD | 41.95% |
| 2023 Q3 | 2.55 Million USD | -17.08% |
| 2022 Q4 | 7.97 Million USD | -7.37% |
| 2022 Q3 | 8.61 Million USD | -31.5% |
| 2022 Q1 | 18.12 Million USD | 84.1% |
| 2022 FY | 7.97 Million USD | -18.96% |
| 2022 Q2 | 12.57 Million USD | -30.62% |
| 2021 Q3 | 15.18 Million USD | -36.15% |
| 2021 Q4 | 9.84 Million USD | -35.2% |
| 2021 Q1 | 30.68 Million USD | 162.21% |
| 2021 FY | 9.84 Million USD | -15.89% |
| 2021 Q2 | 23.78 Million USD | -22.47% |
| 2020 Q2 | 3.09 Million USD | -36.51% |
| 2020 Q4 | 11.7 Million USD | -37.51% |
| 2020 FY | 11.7 Million USD | 154.17% |
| 2020 Q1 | 4.88 Million USD | 6.02% |
| 2020 Q3 | 18.72 Million USD | 504.23% |
| 2019 Q4 | 4.6 Million USD | -57.41% |
| 2019 Q2 | 7.12 Million USD | -46.43% |
| 2019 Q1 | 13.29 Million USD | -39.65% |
| 2019 FY | 4.6 Million USD | -79.1% |
| 2019 Q3 | 10.81 Million USD | 51.8% |
| 2018 Q1 | 4.94 Million USD | -11.28% |
| 2018 FY | 22.02 Million USD | 295.12% |
| 2018 Q4 | 22.02 Million USD | -26.28% |
| 2018 Q3 | 29.88 Million USD | 533.74% |
| 2018 Q2 | 4.71 Million USD | -4.67% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 5.57 Million USD | 0.0% |
| 2017 FY | 5.57 Million USD | 96.16% |
| 2016 FY | 2.84 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| America Great Health | 299.12 Thousand USD | -1113.858% |
| Ampio Pharmaceuticals, Inc. | 5.73 Million USD | 36.698% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | 75.291% |
| Biora Therapeutics, Inc. | 31.21 Million USD | 88.368% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -12.764% |
| Better Therapeutics, Inc. | 22.94 Million USD | 84.174% |
| Calithera Biosciences, Inc. | 28.67 Million USD | 87.338% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | 2.579% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | 82.326% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | 82.81% |
| Evelo Biosciences, Inc. | 64.44 Million USD | 94.365% |
| Evolutionary Genomics, Inc. | 2.35 Million USD | -54.267% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | 94.886% |
| Galera Therapeutics, Inc. | 26.14 Million USD | 86.11% |
| Innovation1 Biotech Inc. | 75.99 Thousand USD | -4678.072% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | 70.162% |
| Molecular Templates, Inc. | 35.38 Million USD | 89.738% |
| Navidea Biopharmaceuticals, Inc. | 4.37 Million USD | 16.941% |
| NexImmune, Inc. | 8.59 Million USD | 57.749% |
| Orgenesis Inc. | 14.55 Million USD | 75.048% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | 69.234% |
| Point of Care Nano-Technology, Inc. | 124.64 Thousand USD | -2813.12% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | 36.079% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -825.65% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | 99.232% |
| Statera Biopharma, Inc. | 21.16 Million USD | 82.848% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | 64.067% |
| Trevena, Inc. | 40.6 Million USD | 91.058% |
| Vaxxinity, Inc. | 44.35 Million USD | 91.813% |
| Vicapsys Life Sciences, Inc. | 39.65 Thousand USD | -9056.244% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | 93.595% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -553.392% |